[COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]

Area of Science:

• Cardiology
• Nephrology
• Infectious Diseases

Background:

• The SARS-CoV-2 pandemic presents a global health emergency.
• Patients with pre-existing cardiovascular and kidney conditions are at increased risk of severe COVID-19 outcomes, including higher morbidity and mortality.
• Vascular lesions and cardiovascular/renal complications are significant concerns during and post-COVID-19 infection.

Purpose of the Study:

• To highlight the heightened vulnerability of patients with cardiovascular and kidney risks during the SARS-CoV-2 pandemic.
• To emphasize the ongoing need for care and intensified monitoring of chronic diseases amidst the pandemic.
• To underscore the importance of research in improving cardiovascular and renal prognosis for COVID-19 patients.

Main Methods:

• This study is a review and expert opinion piece, synthesizing current understanding of COVID-19's impact on cardiovascular and renal health.
• It emphasizes the critical role of primary care in managing patients with cardiovascular disease.
• The abstract calls for intensified monitoring and control of cardiovascular and kidney diseases.

Main Results:

• Patients with cardiovascular and kidney risks experience greater morbidity and mortality from COVID-19.
• A significant proportion of patients develop vascular lesions, increasing lethality.
• Cardiovascular and renal complications pose a future threat to COVID-19 survivors.

Conclusions:

• Intensified control and monitoring of cardiovascular and kidney diseases are essential during the epidemic and the post-COVID-19 period.
• Primary care physicians play a vital role in managing these patients.
• Further research is crucial to enhance cardiovascular and renal prognosis in the context of COVID-19.